{"pmid":32426999,"title":"Gnotobiotic Rats Reveal that Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.","text":["Gnotobiotic Rats Reveal that Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.","N/A.","Hypertension","Yang, Tao","Chakraborty, Saroj","Saha, Piu","Mell, Blair","Cheng, Xi","Yeo, Ji-Youn","Mei, Xue","Zhou, Guannan","Mandal, Juthika","Golonka, Rachel","Yeoh, Beng San","Putluri, Vasanta","Piyarathna, Danthasinghe Waduge Badrajee","Putluri, Nagireddy","McCarthy, Cameron G","Wenceslau, Camilla F","Sreekumar, Arun","Gewirtz, Andrew","Vijay-Kumar, Matam","Joe, Bina","32426999"],"abstract":["N/A."],"journal":"Hypertension","authors":["Yang, Tao","Chakraborty, Saroj","Saha, Piu","Mell, Blair","Cheng, Xi","Yeo, Ji-Youn","Mei, Xue","Zhou, Guannan","Mandal, Juthika","Golonka, Rachel","Yeoh, Beng San","Putluri, Vasanta","Piyarathna, Danthasinghe Waduge Badrajee","Putluri, Nagireddy","McCarthy, Cameron G","Wenceslau, Camilla F","Sreekumar, Arun","Gewirtz, Andrew","Vijay-Kumar, Matam","Joe, Bina"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426999","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1161/HYPERTENSIONAHA.120.15360","keywords":["gut microbiota","sars-cov-2"],"topics":["Mechanism"],"weight":1,"_version_":1667252837985288192,"score":9.490897,"similar":[{"pmid":32326509,"title":"From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.","text":["From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation.","Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh or frozen fecal microorganisms from a healthy donor into the intestinal tract of diseased patients. At this time, in according to healthcare authorities, FMT is mainly used to treat recurrent Clostridium difficile. Despite the existence of a few existing stool banks worldwide and many studies of the FMT, there is no standard method for producing material for FMT, and there are a multitude of factors that can vary between the institutions. The main constraints for the therapeutic uses of FMT are safety concerns and acceptability. Technical and logistical issues arise when establishing such a non-standardized treatment into clinical practice with safety and proper governance. In this context, our manuscript describes a process of donor safety screening for FMT compiling clinical and biological examinations, questionnaires and interviews of donors. The potential risk of transmission of SARS-CoV-2 virus by the use of fecal microbiota for transplantation must be taken urgently into consideration. We discuss a standardized procedure of collection, preparation and cryopreservation of fecal samples through to the administration of material to patients, and explore the risks and limits of this method of FMT. The future success of medicine employing microbiota transplantation will be tightly related to its modulation and manipulation to combat dysbiosis. To achieve this goal, standard and strict methods need to be established before performing any type of FMT.","Diseases","Nicco, Carole","Paule, Armelle","Konturek, Peter","Edeas, Marvin","32326509"],"abstract":["Fecal Microbiota Transplantation (FMT) is suggested as an efficacious therapeutic strategy for restoring intestinal microbial balance, and thus for treating disease associated with alteration of gut microbiota. FMT consists of the administration of fresh or frozen fecal microorganisms from a healthy donor into the intestinal tract of diseased patients. At this time, in according to healthcare authorities, FMT is mainly used to treat recurrent Clostridium difficile. Despite the existence of a few existing stool banks worldwide and many studies of the FMT, there is no standard method for producing material for FMT, and there are a multitude of factors that can vary between the institutions. The main constraints for the therapeutic uses of FMT are safety concerns and acceptability. Technical and logistical issues arise when establishing such a non-standardized treatment into clinical practice with safety and proper governance. In this context, our manuscript describes a process of donor safety screening for FMT compiling clinical and biological examinations, questionnaires and interviews of donors. The potential risk of transmission of SARS-CoV-2 virus by the use of fecal microbiota for transplantation must be taken urgently into consideration. We discuss a standardized procedure of collection, preparation and cryopreservation of fecal samples through to the administration of material to patients, and explore the risks and limits of this method of FMT. The future success of medicine employing microbiota transplantation will be tightly related to its modulation and manipulation to combat dysbiosis. To achieve this goal, standard and strict methods need to be established before performing any type of FMT."],"journal":"Diseases","authors":["Nicco, Carole","Paule, Armelle","Konturek, Peter","Edeas, Marvin"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32326509","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3390/diseases8020009","keywords":["covid-19","fmt","cryoconservation","fecal microbiota transplantation","fecal samples","gut microbiota","stool banks"],"topics":["Prevention"],"weight":1,"_version_":1666138494753308672,"score":57.867805},{"pmid":32430279,"title":"Gut microbiota and Covid-19- possible link and implications.","text":["Gut microbiota and Covid-19- possible link and implications.","Covid-19 is a major pandemic facing the world today caused by SARS-CoV-2 which has implications on our understanding of infectious diseases. Although, SARS-Cov-2 primarily causes lung infection through binding of ACE2 receptors present on the alveolar epithelial cells, yet it was recently reported that SARS-CoV-2 RNA was found in the faeces of infected patients. Interestingly, the intestinal epithelial cells particularly the enterocytes of the small intestine also express ACE2 receptors. Role of the gut microbiota in influencing lung diseases has been well articulated. It is also known that respiratory virus infection causes perturbations in the gut microbiota. Diet, environmental factors and genetics play an important role in shaping gut microbiota which can influence immunity. Gut microbiota diversity is decreased in old age and Covid-19 has been mainly fatal in elderly patients which again points to the role the gut microbiota may play in this disease. Improving gut microbiota profile by personalized nutrition and supplementation known to improve immunity can be one of the prophylactic ways by which the impact of this disease can be minimized in old people and immune-compromised patients. More trials may be initiated to see the effect of co-supplementation of personalized functional food including prebiotics/probiotics along with current therapies.","Virus Res","Dhar, Debojyoti","Mohanty, Abhishek","32430279"],"abstract":["Covid-19 is a major pandemic facing the world today caused by SARS-CoV-2 which has implications on our understanding of infectious diseases. Although, SARS-Cov-2 primarily causes lung infection through binding of ACE2 receptors present on the alveolar epithelial cells, yet it was recently reported that SARS-CoV-2 RNA was found in the faeces of infected patients. Interestingly, the intestinal epithelial cells particularly the enterocytes of the small intestine also express ACE2 receptors. Role of the gut microbiota in influencing lung diseases has been well articulated. It is also known that respiratory virus infection causes perturbations in the gut microbiota. Diet, environmental factors and genetics play an important role in shaping gut microbiota which can influence immunity. Gut microbiota diversity is decreased in old age and Covid-19 has been mainly fatal in elderly patients which again points to the role the gut microbiota may play in this disease. Improving gut microbiota profile by personalized nutrition and supplementation known to improve immunity can be one of the prophylactic ways by which the impact of this disease can be minimized in old people and immune-compromised patients. More trials may be initiated to see the effect of co-supplementation of personalized functional food including prebiotics/probiotics along with current therapies."],"journal":"Virus Res","authors":["Dhar, Debojyoti","Mohanty, Abhishek"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32430279","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.virusres.2020.198018","keywords":["covid-19","diet","dysbiosis","gut microbiome","immunity","lung microbiota","sars-cov-2"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667342288381018112,"score":57.39214},{"pmid":32302706,"pmcid":"PMC7194807","title":"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.","text":["Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.","The renin-angiotensin system (RAS) is crucial for the physiology and pathology of all the organs. Angiotensin-converting enzyme 2 (ACE2) maintains the homeostasis of RAS as a negative regulator. Recently, ACE2 was identified as the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus that is causing the pandemic of Coronavirus disease 2019 (COVID-19). Since SARS-CoV-2 must bind with ACE2 before entering the host cells in humans, the distribution and expression of ACE2 may be critical for the target organ of the SARS-CoV-2 infection. Moreover, accumulating evidence has demonstrated the implication of ACE2 in the pathological progression in tissue injury and several chronic diseases, ACE2 may also be essential in the progression and clinical outcomes of COVID-19. Therefore, we summarized the expression and activity of ACE2 in various physiological and pathological conditions, and discussed its potential implication in the susceptibility of SARS-CoV-2 infection and the progression and prognosis of COVID-19 patients in the current review.","Pharmacol Res","Li, Yanwei","Zhou, Wei","Yang, Li","You, Ran","32302706"],"abstract":["The renin-angiotensin system (RAS) is crucial for the physiology and pathology of all the organs. Angiotensin-converting enzyme 2 (ACE2) maintains the homeostasis of RAS as a negative regulator. Recently, ACE2 was identified as the receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus that is causing the pandemic of Coronavirus disease 2019 (COVID-19). Since SARS-CoV-2 must bind with ACE2 before entering the host cells in humans, the distribution and expression of ACE2 may be critical for the target organ of the SARS-CoV-2 infection. Moreover, accumulating evidence has demonstrated the implication of ACE2 in the pathological progression in tissue injury and several chronic diseases, ACE2 may also be essential in the progression and clinical outcomes of COVID-19. Therefore, we summarized the expression and activity of ACE2 in various physiological and pathological conditions, and discussed its potential implication in the susceptibility of SARS-CoV-2 infection and the progression and prognosis of COVID-19 patients in the current review."],"journal":"Pharmacol Res","authors":["Li, Yanwei","Zhou, Wei","Yang, Li","You, Ran"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302706","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.phrs.2020.104833","keywords":["angiotensin-converting enzyme 2","coronavirus disease 2019","diminazene aceturate (pubchem cid: 5284544)","resorcinolnaphthalein (pubchem cid: 337218)","severe acute respiratory syndrome coronavirus 2","xanthenone (pubchem cid: 7020)"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494760648704,"score":49.983826},{"pmid":32379863,"title":"Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization.","text":["Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization.","BACKGROUND: More than two months separated the initial description of SARS-CoV-2 and discovery of its widespread dissemination in the United States. Despite this lengthy interval, implementation of specific quantitative reverse transcription (qRT)-PCR-based SARS-CoV-2 tests in the US has been slow, and testing is still not widely available. Metagenomic sequencing offers the promise of unbiased detection of emerging pathogens, without requiring prior knowledge of the identity of the responsible agent or its genomic sequence. METHODS: To evaluate metagenomic approaches in the context of the current SARS-CoV-2 epidemic, laboratory-confirmed positive and negative samples from Seattle, Washington were evaluated by metagenomic sequencing, with comparison to a 2019 reference genomic database created before the emergence of SARS-CoV-2. RESULTS: Within 36 hours our results showed clear identification of a novel human Betacoronavirus, closely related to known Betacoronaviruses of bats, in laboratory-proven cases of SARS-CoV-2. A subset of samples also showed superinfection or colonization with human parainfluenza virus 3 or Moraxella species, highlighting the need to test directly for SARS-CoV-2 as opposed to ruling out an infection using a viral respiratory panel. Samples negative for SARS-CoV-2 by RT-PCR were also negative by metagenomic analysis, and positive for Rhinovirus A and C. Unlike targeted SARS-CoV-2 qRT-PCR testing, metagenomic analysis of these SARS-CoV-2 negative samples identified candidate etiological agents for the patients' respiratory symptoms. CONCLUSION: Taken together, these results demonstrate the value of metagenomic analysis in the monitoring and response to this and future viral pandemics.","Clin Chem","Peddu, Vikas","Shean, Ryan C","Xie, Hong","Shrestha, Lasata","Perchetti, Garrett A","Minot, Samuel S","Roychoudhury, Pavitra","Huang, Meei-Li","Nalla, Arun","Reddy, Shriya B","Phung, Quynh","Reinhardt, Adam","Jerome, Keith R","Greninger, Alexander L","32379863"],"abstract":["BACKGROUND: More than two months separated the initial description of SARS-CoV-2 and discovery of its widespread dissemination in the United States. Despite this lengthy interval, implementation of specific quantitative reverse transcription (qRT)-PCR-based SARS-CoV-2 tests in the US has been slow, and testing is still not widely available. Metagenomic sequencing offers the promise of unbiased detection of emerging pathogens, without requiring prior knowledge of the identity of the responsible agent or its genomic sequence. METHODS: To evaluate metagenomic approaches in the context of the current SARS-CoV-2 epidemic, laboratory-confirmed positive and negative samples from Seattle, Washington were evaluated by metagenomic sequencing, with comparison to a 2019 reference genomic database created before the emergence of SARS-CoV-2. RESULTS: Within 36 hours our results showed clear identification of a novel human Betacoronavirus, closely related to known Betacoronaviruses of bats, in laboratory-proven cases of SARS-CoV-2. A subset of samples also showed superinfection or colonization with human parainfluenza virus 3 or Moraxella species, highlighting the need to test directly for SARS-CoV-2 as opposed to ruling out an infection using a viral respiratory panel. Samples negative for SARS-CoV-2 by RT-PCR were also negative by metagenomic analysis, and positive for Rhinovirus A and C. Unlike targeted SARS-CoV-2 qRT-PCR testing, metagenomic analysis of these SARS-CoV-2 negative samples identified candidate etiological agents for the patients' respiratory symptoms. CONCLUSION: Taken together, these results demonstrate the value of metagenomic analysis in the monitoring and response to this and future viral pandemics."],"journal":"Clin Chem","authors":["Peddu, Vikas","Shean, Ryan C","Xie, Hong","Shrestha, Lasata","Perchetti, Garrett A","Minot, Samuel S","Roychoudhury, Pavitra","Huang, Meei-Li","Nalla, Arun","Reddy, Shriya B","Phung, Quynh","Reinhardt, Adam","Jerome, Keith R","Greninger, Alexander L"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379863","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/clinchem/hvaa106","locations":["United States","US","Seattle","Washington"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666262687616598016,"score":46.79491},{"pmid":32432918,"title":"Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.","text":["Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.","There is marked sexual dimorphism in the current COVID-19 pandemic. Here we report that estrogen can regulate the expression of ACE2, a key component for SARS-CoV-2 cell entry, in differentiated airway epithelial cells. Further studies are required to elucidate the mechanisms by which sex steroids regulate SARS-CoV-2 infectivity.","Am J Physiol Lung Cell Mol Physiol","Stelzig, Kimberly E","Canepa-Escaro, Fabrizio","Schiliro, Marta","Berdnikovs, Sergejs","Prakash, Y S","Chiarella, Sergio E","32432918"],"abstract":["There is marked sexual dimorphism in the current COVID-19 pandemic. Here we report that estrogen can regulate the expression of ACE2, a key component for SARS-CoV-2 cell entry, in differentiated airway epithelial cells. Further studies are required to elucidate the mechanisms by which sex steroids regulate SARS-CoV-2 infectivity."],"journal":"Am J Physiol Lung Cell Mol Physiol","authors":["Stelzig, Kimberly E","Canepa-Escaro, Fabrizio","Schiliro, Marta","Berdnikovs, Sergejs","Prakash, Y S","Chiarella, Sergio E"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432918","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1152/ajplung.00153.2020","keywords":["covid-19","sars-cov-2","coronavirus","epithelial","estrogen"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667342288215343105,"score":44.89938}]}